TheraPanacea
Olivier Teboul has a diverse work experience in the field of machine learning and software development. Olivier is currently the Director of Machine Learning and Software Development at TheraPanacea, starting in March 2022. Prior to this, they worked at Google as a Staff Software Engineer from February 2019 to March 2022. Before Google, they were the CTO and co-founder of Brother Tongue from August 2016 to February 2019. Olivier also worked as a Software Engineer at WorldSense for a brief period from March 2016 to June 2016. Olivier started their career at Google as a Senior Software Engineer in August 2011 and stayed there until February 2016. Olivier holds a PhD in Computer Vision from CentraleSupélec, where they conducted research under the supervision of Nikos Paragios. During their PhD, they had publications in prestigious conferences such as ICCV 09, CVPR 10, CVPR 11, and MICCAI, as well as in the TPAMI journal (2013).
From 2004 to 2007, Olivier Teboul attended CentraleSupélec and obtained a Master's Degree in Engineering and Data Science.
TheraPanacea
TheraPanacea is an innovative information technology company devoted to unlocking the power of AI-based solutions to drive innovation in healthcare. A spin-off of University Paris-Saclay, TheraPanacea works in close cooperation with the most prominent healthcare facilities to combine the power of its proprietary platforms with clinical domain-knowledge. Today, ART-Plan™, TheraPanacea dedicated suite for radio-oncology, is used by more than 60 cancer centres across Europe, Africa, Middle-East and the US and is helping to improve care for more than 60,000 patients every year. TheraPanacea also develops and operates the ART-Omics™ platform enabling pharmaceutical companies to accelerate clinical research by harnessing AI-based multi-modality biomarker discovery in clinical trials and their effective integration within the clinical workflow at scale in the form of certified medical devices.